Back to Search
SUSAN ANSORGE, PH.D.
PH.D.
Clinical Psychologist
NPI: 1598813628Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
25813(TX)
Research & Publications (20)
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
PMID 19676138·Clin Chem Lab Med·2009
7-preclinical
Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
PMID 19394958·J Psychiatr Res·2009
7-preclinical
Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions.
PMID 19327105·Clin Chem Lab Med·2009
6-review
Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
PMID 19618482·J Gene Med·2009
8-other
The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.
PMID 17981718·Front Biosci·2008
6-review
DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.
PMID 17981717·Front Biosci·2008
6-review
Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.
PMID 17943180·J Invest Dermatol·2008
7-preclinical
Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary.
PMID 18226493·J Chem Neuroanat·2008
8-other
Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors.
PMID 18508466·Front Biosci·2008
6-review
[Alternative materials and solutions in total knee arthroplasty for patients with metal allergy].
PMID 18210089·Orthopade·2008
6-review
Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
PMID 17786278·Int J Mol Med·2007
7-preclinical
On-line monitoring of infected Sf-9 insect cell cultures by scanning permittivity measurements and comparison with off-line biovolume measurements.
PMID 19003001·Cytotechnology·2007
8-other
Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
PMID 16778789·J Invest Dermatol·2007
8-other
TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
PMID 17372022·J Immunol·2007
7-preclinical
Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.
PMID 17911455·Ann N Y Acad Sci·2007
6-review
Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.
PMID 16614941·J Neurooncol·2006
8-other
Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
PMID 17161346·Int Immunopharmacol·2006
7-preclinical
Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
PMID 16700521·Adv Exp Med Biol·2006
7-preclinical
Assigning the phenotype of a natural regulatory T-cell to the human T-cell line, KARPAS-299.
PMID 16391826·Int J Mol Med·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3908 RIDGELEA DR
AUSTIN, TX 78731 - Phone
- (512) 797-3654
Quick Facts
- NPI
- 1598813628
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile